SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech failure, 2002
An SI Board Since January 2002
Posts SubjectMarks Bans
130 20 0
Emcee:  Miljenko Zuanic Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
30Angiotech Pharmaceuticals, Inc.: Phase 2 Multiple Sclerosis Trial Fails to Meet keokalani'nui-2/25/2002
29Same ol', same ol'.... ================ Friday February 22, 1:32 am Eascott_jiminez-2/22/2002
28AVANT Announces Preliminary Results of its Phase II Study of TP10 in Adults Undekeokalani'nui-2/20/2002
27Looks like the end for Bioglan - LONDON, Feb 20 (Reuters) - The outlook for debnigel bates-2/20/2002
26This is not real T-20 failure, but results were at lower end. Tuesday February Miljenko Zuanic-2/19/2002
25Drug aimed at choking tumor blood vessels fails By Ransdell Pierson NEW YORK, Fmichael_f_murphy-2/8/2002
24Pharmacia Cancer Drug Halted Matthew Herper Forbes.com 02.08.02, 3:51 PM ET michael_f_murphy-2/8/2002
23Thursday February 7, 12:01 am Eastern Time Press Release SOURCE: Genentech PhaseMiljenko Zuanic-2/7/2002
22Here are some ELN price targets from July to September. I've listed BrokeraJFitnich-2/6/2002
21>> Earning surprise for '02 is issue here and will not go away quicklyscaram(o)uche-2/4/2002
20<<This is fascinating. Can't wait to watch how this plays out. We'Miljenko Zuanic-2/4/2002
19>> Enron spill ower, or problems with revenue growth? << Both. Butscaram(o)uche-2/4/2002
18Enron spill ower, or problems with revenue growth? Monday February 4, 8:20 am EMiljenko Zuanic-2/4/2002
17Is gene-therapy at another roadblock, or is GVEC going to be beneficial in this Miljenko Zuanic-1/24/2002
16Thanks Scottsso-1/20/2002
15Erbitux is a monoclonal antibody against the EGF-receptor. The idea of blockingscott_jiminez-1/20/2002
14Scott, Thanks for your reply Actually my question was, is there any evidence tsso-1/20/2002
13<<Is there any independent evidence that this compound works like they sayscott_jiminez-1/20/2002
12Is there any independent evidence that this compound works like they say it doessso-1/20/2002
11This (Pravachol combo failure) certainly does not augur well for the likes of POhmpa-1/19/2002
10It is from pharma, but it is noteworthy. Friday January 18, 4:20 pm Eastern TimMiljenko Zuanic-1/19/2002
9More on ImClone... Message 16934057scott_jiminez-1/19/2002
8And again today from IMCL. When we will have day when there is no bad news for Miljenko Zuanic-1/18/2002
7Thursday January 17, 7:15 pm Eastern Time Press Release SOURCE: Elan CorporationMiljenko Zuanic-1/17/2002
6Cubist flattened. ==================== Wednesday January 16, 5:47 pm Eastern Tscott_jiminez-1/16/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News